Stock 3118 LEVEL BIOTECHNOLOGY INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Level Biotechnology Inc.

Equities

3118

TW0003118006

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange
Other stock markets
 23:00:00 20/06/2024 BST 		5-day change 1st Jan Change
34.35 TWD -0.87% Intraday chart for Level Biotechnology Inc. -3.51% +12.81%
05-14 Level Biotechnology Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-13 Level Biotechnology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 918.4 876.2 972 972 897.3 988.2
Enterprise Value (EV) 1 645.6 549 607.5 512.2 446.4 534.2
P/E ratio 23.8 x 18.6 x 16.8 x 14.3 x 15.4 x 15.8 x
Yield 3.53% - 5.34% 6.34% 6.15% 5.58%
Capitalization / Revenue 1.46 x 1.37 x 1.45 x 1.44 x 1.51 x 1.5 x
EV / Revenue 1.03 x 0.86 x 0.9 x 0.76 x 0.75 x 0.81 x
EV / EBITDA 9.84 x 7.45 x 7.3 x 5.38 x 5.53 x 6.42 x
EV / FCF 49.4 x 5.83 x 9.53 x 4.01 x 10.9 x 13.1 x
FCF Yield 2.02% 17.1% 10.5% 24.9% 9.17% 7.62%
Price to Book 1.84 x 1.71 x 1.84 x 1.78 x 1.65 x 1.8 x
Nbr of stocks (in thousands) 32,453 32,453 32,453 32,453 32,453 32,453
Reference price 2 28.30 27.00 29.95 29.95 27.65 30.45
Announcement Date 29/03/19 29/03/20 19/03/21 24/03/22 21/03/23 13/03/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 629 638.9 672.5 677.3 593 660.6
EBITDA 1 65.58 73.69 83.18 95.15 80.72 83.2
EBIT 1 49.16 56.45 65.91 78.96 64.9 67.55
Operating Margin 7.82% 8.83% 9.8% 11.66% 10.94% 10.23%
Earnings before Tax (EBT) 1 49.28 59.37 72.54 84.89 73.16 78.65
Net income 1 38.91 47.4 58.04 68.18 58.47 62.9
Net margin 6.19% 7.42% 8.63% 10.07% 9.86% 9.52%
EPS 2 1.190 1.450 1.780 2.090 1.790 1.930
Free Cash Flow 1 13.07 94.13 63.75 127.7 40.94 40.7
FCF margin 2.08% 14.73% 9.48% 18.86% 6.9% 6.16%
FCF Conversion (EBITDA) 19.93% 127.73% 76.64% 134.22% 50.71% 48.92%
FCF Conversion (Net income) 33.59% 198.6% 109.84% 187.32% 70.02% 64.71%
Dividend per Share 2 1.000 - 1.600 1.900 1.700 1.700
Announcement Date 29/03/19 29/03/20 19/03/21 24/03/22 21/03/23 13/03/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 273 327 364 460 451 454
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 13.1 94.1 63.8 128 40.9 40.7
ROE (net income / shareholders' equity) 7.62% 9.36% 11.1% 12.7% 10.8% 11.5%
ROA (Net income/ Total Assets) 4.35% 4.93% 5.41% 6.32% 5.07% 5.16%
Assets 1 894.6 961 1,073 1,078 1,153 1,218
Book Value Per Share 2 15.40 15.80 16.30 16.80 16.70 16.90
Cash Flow per Share 2 8.410 10.60 11.70 14.60 14.30 14.40
Capex 1 2.51 2.43 2.54 9.16 6.74 7.67
Capex / Sales 0.4% 0.38% 0.38% 1.35% 1.14% 1.16%
Announcement Date 29/03/19 29/03/20 19/03/21 24/03/22 21/03/23 13/03/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
LEVEL BIOTECHNOLOGY INC. Stock Level Biotechnology Inc.
+12.81% 34.41M
ABBOTT LABORATORIES Stock Abbott Laboratories
-3.95% 184B
MEDTRONIC PLC Stock Medtronic plc
-0.90% 105B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-2.27% 68.87B
CENCORA, INC. Stock Cencora, Inc.
+15.24% 46.61B
DEXCOM, INC. Stock DexCom, Inc.
-6.00% 46.39B
HOYA CORPORATION Stock Hoya Corporation
+6.01% 40.74B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+20.65% 31.26B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-5.50% 24.24B
TERUMO CORPORATION Stock Terumo Corporation
+11.94% 24B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 3118 Stock
  4. Financials Level Biotechnology Inc.